moxisylyte has been researched along with Hyperventilation in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Hyperventilation: A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbett, JL | 1 |
| Eidelman, BH | 1 |
| Debarge, O | 1 |
1 other study available for moxisylyte and Hyperventilation
| Article | Year |
|---|---|
Modification of cerebral vasoconstriction with hyperventilation in normal man by thymoxamine.
Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Brain; Carbon Dioxide; Cerebrovascular Circulat | 1972 |